Company Overview
- Website
- siwatherapeutics.com
- Employees
- 3
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
A Randomized Phase II Trial of Gemcitabine, Nab-Paclitaxel, Cisplatin with or without a Medically Supervised Ketogenic Diet for Patients with Metastatic Pancreatic Cancer
- Jun 9, 2025
- medrxiv.org
Chicago biotech: Seven players advancing the industry
- Apr 2, 2024
- labiotech.eu
DryJect expands franchises into Chicagoland
- Dec 11, 2023
- golfcourseindustry.com
New antibody shows strong potential as treatment against pancreatic cancer
- Oct 27, 2023
- medicalxpress.com
Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer | Scientific Reports
- Oct 7, 2023
- nature.com
Abstract B026: SIWA318H, a novel advanced glycation end product (AGE) specific antibody, targets cancer and senescent cells in the tumor microenvironment and exhibits potent antitumor activity in a humanized mouse model for pancreatic cancer. [R]
- Jan 15, 2023
- aacrjournals.org
Who is SIWA Therapeutics
SIWA Therapeutics is a privately held biotechnology company based in Chicago, Illinois. With a small team of three employees, the company has generated $2.5 million in revenue. SIWA Therapeutics specializes in the development of monoclonal antibodies targeting senescent cells, which are increasingly recognized as contributors to a variety of age-related diseases. Their lead antibody, SIWA 318, is currently undergoing optimization and holds promise for treating rare and fast-track diseases such as cancer metastasis and muscle wasting conditions like muscular dystrophy. The company's focus extends beyond these specific indications, recognizing the broader implications of senescent cells in diseases like neurodegenerative disorders, autoimmune conditions, and infectious diseases. SIWA Therapeutics actively seeks partnerships to expand its development pipeline and accelerate the advancement of its innovative technologies. For more information about SIWA Therapeutics and its groundbreaking research, please visit www.siwatherapeutics.com.
Companies Similar to SIWA Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to SIWA Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |